GPT and metabolic dysfunction-associated steatotic liver disease: Traditional serum markers have limitations: ALT is neither sensitive nor specific as its levels can be normal in many MASLD patients even with advanced disease, and indices like FIB-4 are useful for fibrosis but not designed to detect MASH.